This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Best Momentum Stocks to Buy for February 7th
by Zacks Equity Research
META, AMSC and CLX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 7, 2023.
New Strong Buy Stocks for February 7th
by Zacks Equity Research
AMSC, META, CLX, IPA and KMPR have been added to the Zacks Rank #1 (Strong Buy) List on February 7, 2023.
Best Income Stocks to Buy for February 7th
by Zacks Equity Research
CLX, KMPR and LANC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 7, 2023.
3 Stocks to Buy Following Guidance Lifts
by Derek Lewis
Earnings season continues its rapid pace, with many companies delivering quarterly results daily. And for those seeking earnings positivity, that's precisely what these three companies have delivered.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Mondelez (MDLZ) have performed compared to their sector so far this year.
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
Clorox (CLX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 100% and 12.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
Countdown to Clorox (CLX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Clorox (CLX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Clorox (CLX) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $144.68, marking a +0.37% move from the previous day.
Church & Dwight (CHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Clorox's (CLX) Q2 results are expected to reflect gains from solid demand, cost-saving efforts, strong execution and pricing actions. Its IGNITE strategy and digital investments bode well.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q2 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 8.24% and 0.49%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Clorox (CLX) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $143.35, denoting a -0.57% change from the preceding trading day.
Procter & Gamble (PG) Strong Brands Aid Growth Amid Inflation
by Zacks Equity Research
Procter & Gamble (PG) is navigating market challenges and leveraging growth opportunities in fiscal 2024, showcasing robust sales in key divisions and innovative ventures like Ninjamas.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Imperial Tobacco Group PLC (IMBBY) have performed compared to their sector so far this year.
Why the Market Dipped But Clorox (CLX) Gained Today
by Zacks Equity Research
Clorox (CLX) reachead $142.72 at the closing of the latest trading day, reflecting a +0.95% change compared to its last close.
Clorox (CLX) Navigates Challenges, Poised for Sustained Growth
by Zacks Equity Research
Clorox's (CLX) focus on maintaining competitive pricing, sustained innovation, and adherence to a balanced spending approach bodes well amid input-cost inflation and supply-chain woes.
Clorox (CLX) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Clorox (CLX) reachead $141.29 at the closing of the latest trading day, reflecting a -0.81% change compared to its last close.
Constellation Brands (STZ) Beats Q3 Earnings Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 5.28% and 3.15%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?